Company Valuation: LifeMD, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 118.4 61.01 325 214.4 164.1 179.4 - -
Change - -48.47% 432.67% -34.03% -23.44% 9.31% - -
Enterprise Value (EV) 77.74 61.01 325 214.4 164.1 179.4 179.4 179.4
Change - -21.52% 432.67% -34.03% -23.44% 9.31% 0% 0%
P/E -1.69x -1.24x -11.8x -9.34x -19.5x -13.6x 49.9x 12x
PBR - - - - - - - -
PEG - 0x 0.2x 0.4x 0.3x -0.2x -0x 0x
Capitalization / Revenue 1.27x 0.51x 2.13x 1.01x 0.85x 0.81x 0.69x 0.59x
EV / Revenue 0x 0x 0x 0x 0x 0.81x 0.69x 0.59x
EV / EBITDA -0x -0x 0x 0x 0x 13.6x 5.82x 3.57x
EV / EBIT -0x -0x -0x -0x -0x -18.7x 23.6x 7.58x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -2.29 -1.57 -0.7 -0.53 -0.1753 -0.2729 0.0743 0.31
Distribution rate - - - - - - - -
Net sales 1 92.88 119 152.5 212.5 194.1 222 260.9 302.7
EBITDA 1 -38.28 -14.66 11.98 14.38 15.25 13.22 30.8 50.21
EBIT 1 -54.3 -43.45 -14.49 -16.14 -7.67 -9.572 7.616 23.67
Net income 1 -61.77 -48.64 -23.7 -21.99 -7.913 -13.11 3.574 15.8
Net Debt -40.66 - - - - - - -
Reference price 2 3.870 1.940 8.290 4.950 3.410 3.710 3.710 3.710
Nbr of stocks (in thousands) 30,593 31,450 39,203 43,312 48,136 48,363 - -
Announcement Date 3/7/22 3/22/23 3/11/24 3/10/25 3/9/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-13.6x - - - 179M
29.12x6.32x14x-.--% 30.25B
73.66x63x78.47x0.5% 11.68B
78.1x11.5x49.92x0.75% 5.28B
-30.28x8.47x-45.86x - 2.08B
52.56x - - -.--% 1.86B
-5.86x57.8x-5.85x - 1.72B
-109.61x - - - 1.03B
5.99x - - - 865M
105.33x - - 1.27% 723M
Average 18.54x 29.42x 18.14x 0.5% 5.57B
Weighted average by Cap. 38.52x 21.65x 29.37x 0.21%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. LFMD Stock
  4. Valuation LifeMD, Inc.